- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Thoracic SMARCA4-deficient undifferentiated tumor ; volume:14 ; number:1 ; day:28 ; month:4 ; year:2023 ; pages:1-11 ; date:12.2023
Discover oncology ; 14, Heft 1 (28.4.2023), 1-11, 12.2023
- Urheber
-
Jiang, Jiapeng
Chen, Zhixin
Gong, Jiali
Han, Na
Lu, Hongyang
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12672-023-00639-w
- URN
-
urn:nbn:de:101:1-2023090412174826965736
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jiang, Jiapeng
- Chen, Zhixin
- Gong, Jiali
- Han, Na
- Lu, Hongyang
- SpringerLink (Online service)
Ähnliche Objekte (12)
Promising efficacy of immune checkpoint inhibitor plus chemotherapy for thoracic SMARCA4-deficient undifferentiated tumor
Surgical resection following chemoradiotherapy for thoracic SMARCA4-deficient undifferentiated tumor: a report of two cases
The golden key to open mystery boxes of SMARCA4-deficient undifferentiated thoracic tumor: focusing immunotherapy, tumor microenvironment and epigenetic regulation
Metastatic SMARCA4-deficient undifferentiated tumor in the small mesentery: case report
SMARCA4-deficient thoracic tumor detected by [18F]FDG PET/CT
Gastric SMARCA4-deficient undifferentiated tumor (SMARCA4-UT): a clinicopathological analysis of four rare cases
SMARCA4/SMARCA2-Deficient Undifferentiated Metastatic Malignant Tumor with Carcinoma of Unknown Primary: Case Report
SMARCA2/BRM-Deficient Undifferentiated/Rhabdoid Carcinoma of Unknown Primary Site
Rapidly fatal SMARCA4-deficient undifferentiated sarcoma originating from hybrid hemosiderotic fibrolipomatous tumor/pleomorphic hyalinizing angiectatic tumor of the foot
Rapidly fatal SMARCA4-deficient undifferentiated sarcoma originating from hybrid hemosiderotic fibrolipomatous tumor/pleomorphic hyalinizing angiectatic tumor of the foot
Pathological characteristics and immune microenvironment of SMARCA4-deficient undifferentiated uterine sarcoma
Alternating chemotherapy with VDC-IE as effective first-line treatment in a patient with SMARCA4-deficient undifferentiated tumor
Promising efficacy of immune checkpoint inhibitor plus chemotherapy for thoracic SMARCA4-deficient undifferentiated tumor
Surgical resection following chemoradiotherapy for thoracic SMARCA4-deficient undifferentiated tumor: a report of two cases
The golden key to open mystery boxes of SMARCA4-deficient undifferentiated thoracic tumor: focusing immunotherapy, tumor microenvironment and epigenetic regulation
Metastatic SMARCA4-deficient undifferentiated tumor in the small mesentery: case report
SMARCA4-deficient thoracic tumor detected by [18F]FDG PET/CT
Gastric SMARCA4-deficient undifferentiated tumor (SMARCA4-UT): a clinicopathological analysis of four rare cases
SMARCA4/SMARCA2-Deficient Undifferentiated Metastatic Malignant Tumor with Carcinoma of Unknown Primary: Case Report
SMARCA2/BRM-Deficient Undifferentiated/Rhabdoid Carcinoma of Unknown Primary Site
Rapidly fatal SMARCA4-deficient undifferentiated sarcoma originating from hybrid hemosiderotic fibrolipomatous tumor/pleomorphic hyalinizing angiectatic tumor of the foot
Rapidly fatal SMARCA4-deficient undifferentiated sarcoma originating from hybrid hemosiderotic fibrolipomatous tumor/pleomorphic hyalinizing angiectatic tumor of the foot
Pathological characteristics and immune microenvironment of SMARCA4-deficient undifferentiated uterine sarcoma
Alternating chemotherapy with VDC-IE as effective first-line treatment in a patient with SMARCA4-deficient undifferentiated tumor
Promising efficacy of immune checkpoint inhibitor plus chemotherapy for thoracic SMARCA4-deficient undifferentiated tumor
Surgical resection following chemoradiotherapy for thoracic SMARCA4-deficient undifferentiated tumor: a report of two cases
The golden key to open mystery boxes of SMARCA4-deficient undifferentiated thoracic tumor: focusing immunotherapy, tumor microenvironment and epigenetic regulation
Metastatic SMARCA4-deficient undifferentiated tumor in the small mesentery: case report
SMARCA4-deficient thoracic tumor detected by [18F]FDG PET/CT
Gastric SMARCA4-deficient undifferentiated tumor (SMARCA4-UT): a clinicopathological analysis of four rare cases
SMARCA4/SMARCA2-Deficient Undifferentiated Metastatic Malignant Tumor with Carcinoma of Unknown Primary: Case Report
SMARCA2/BRM-Deficient Undifferentiated/Rhabdoid Carcinoma of Unknown Primary Site
Rapidly fatal SMARCA4-deficient undifferentiated sarcoma originating from hybrid hemosiderotic fibrolipomatous tumor/pleomorphic hyalinizing angiectatic tumor of the foot
Rapidly fatal SMARCA4-deficient undifferentiated sarcoma originating from hybrid hemosiderotic fibrolipomatous tumor/pleomorphic hyalinizing angiectatic tumor of the foot
Pathological characteristics and immune microenvironment of SMARCA4-deficient undifferentiated uterine sarcoma